NCT03393858 2024-02-07Combination of Immunotherapy and Hyperthermia in Advanced Malignant MesotheliomaCapital Medical UniversityPhase 1/2 Terminated10 enrolled
NCT02900664 2022-03-29A Study of PDR001 in Combination With CJM112, EGF816, IlarisĀ® (Canakinumab) or MekinistĀ® (Trametinib)NovartisPhase 1 Completed283 enrolled